Concentrix Net Income Soars 430% on Strong Revenue Growth

Ticker: CNXC · Form: 10-Q · Filed: Oct 3, 2025 · CIK: 1803599

Concentrix CORP 10-Q Filing Summary
FieldDetail
CompanyConcentrix CORP (CNXC)
Form Type10-Q
Filed DateOct 3, 2025
Risk Levelmedium
Pages16
Reading Time19 min
Key Dollar Amounts$0.0001
Sentimentbullish

Sentiment: bullish

Topics: Earnings Growth, Revenue Growth, Customer Experience, Digital Transformation, Acquisition Integration, Share Repurchase, Financial Services

Related Tickers: CNXC, TTEC, TEL

TL;DR

**CNXC's massive net income jump makes it a strong buy, signaling successful Webhelp integration and operational leverage.**

AI Summary

Concentrix Corp (CNXC) reported a robust financial performance for the three and nine months ended August 31, 2025. Revenue increased by 4.0% to $2.48 billion for the three months ended August 31, 2025, up from $2.39 billion in the prior year period. Net income saw a significant jump, rising 430% to $88.11 million for the three-month period, compared to $16.63 million in the same period last year. For the nine months ended August 31, 2025, revenue grew to $7.27 billion from $7.17 billion, a 1.4% increase, while net income surged 47.9% to $200.46 million from $135.57 million. The company's cash and cash equivalents increased to $350.26 million as of August 31, 2025, from $240.57 million at November 30, 2024. Key business changes include the ongoing integration of Webhelp, acquired in September 2023, which continues to impact financial metrics. Risks include potential impacts from new accounting pronouncements, though the company is still evaluating these. Strategic outlook appears positive, with increased share-based compensation activity and a focus on end-to-end solutions for clients.

Why It Matters

This significant surge in net income and steady revenue growth for Concentrix signals strong operational efficiency and successful integration post-Webhelp acquisition, which is crucial for investor confidence. For employees, this performance could indicate job stability and potential for growth within a thriving company. Customers benefit from Concentrix's expanded capabilities in CX process optimization and digital operations, enhancing their brand experiences. In the broader market, Concentrix's robust results highlight its competitive edge in the global technology and services sector, especially against rivals like Teleperformance and TTEC, demonstrating its ability to capture market share and deliver value.

Risk Assessment

Risk Level: medium — While net income surged, the company's long-term debt remains substantial at $4.79 billion as of August 31, 2025, and they used $211.44 million in cash for financing activities during the nine months ended August 31, 2025. Additionally, the company is evaluating the impact of several new FASB accounting pronouncements, including ASU 2023-07, ASU 2023-09, ASU 2024-03, and ASU 2025-06, which could introduce future reporting complexities or financial adjustments.

Analyst Insight

Investors should consider increasing their position in CNXC, given the impressive 430% net income growth and stable revenue. Monitor the integration progress of Webhelp and the company's ability to manage its substantial long-term debt, but the current operational performance suggests strong underlying business health.

Financial Highlights

debt To Equity
1.86
revenue
$2.48B
operating Margin
5.9%
total Assets
$12.41B
total Debt
$4.83B
net Income
$88.11M
eps
$1.34
gross Margin
34.4%
cash Position
$350.26M
revenue Growth
+4.0%

Key Numbers

Key Players & Entities

FAQ

What were Concentrix Corporation's key financial results for the quarter ended August 31, 2025?

Concentrix Corporation reported revenue of $2.48 billion for the three months ended August 31, 2025, a 4.0% increase from the prior year. Net income surged 430% to $88.11 million, up from $16.63 million in the same period last year.

How did Concentrix's nine-month performance compare to the previous year?

For the nine months ended August 31, 2025, Concentrix's revenue increased 1.4% to $7.27 billion, compared to $7.17 billion in the prior year. Net income for the nine-month period rose 47.9% to $200.46 million from $135.57 million.

What is the impact of the Webhelp acquisition on Concentrix's financials?

The Webhelp Combination, completed on September 25, 2023, continues to be integrated. While specific financial impacts are not fully disaggregated in this 10-Q, the overall strong performance suggests successful integration contributing to revenue and net income growth.

What are the primary risks Concentrix is facing according to the 10-Q?

Concentrix faces risks related to its substantial long-term debt of $4.79 billion and the ongoing evaluation of new FASB accounting pronouncements (ASU 2023-07, 2023-09, 2024-03, 2025-06) which could impact future disclosures and financial reporting.

How has Concentrix's cash position changed?

Cash and cash equivalents increased to $350.26 million as of August 31, 2025, from $240.57 million at November 30, 2024. However, net cash used in financing activities was $211.44 million for the nine months ended August 31, 2025.

What is Concentrix doing with its common stock?

Concentrix repurchased $112.77 million of common stock during the nine months ended August 31, 2025, and paid $66.39 million in dividends, indicating a commitment to returning value to shareholders.

Are there any significant client concentration risks for Concentrix?

No, the filing states that for the three and nine months ended August 31, 2025 and 2024, no client accounted for more than 10% of Concentrix's consolidated revenue or total accounts receivable balance.

What new accounting standards might affect Concentrix in the future?

Concentrix is evaluating ASU 2023-07 (segment disclosures, effective FY2025), ASU 2023-09 (income tax disclosures, effective FY2026), ASU 2024-03 (expense disaggregation, effective FY2028), and ASU 2025-06 (internal-use software, effective FY2029).

What is Concentrix's business model?

Concentrix is a global technology and services leader that designs, builds, and runs fully integrated, end-to-end solutions including customer experience process optimization, technology innovation, automation, analytics, and business transformation services for clients across five primary industry verticals.

How much share-based compensation expense did Concentrix record?

Concentrix recorded share-based compensation expense of $25.04 million for the three months ended August 31, 2025, and $78.50 million for the nine months ended August 31, 2025, included in selling, general and administrative expenses.

Risk Factors

Industry Context

Concentrix operates in the highly competitive global business process outsourcing (BPO) and customer experience (CX) management industry. Key trends include the increasing demand for digital transformation, AI-powered solutions, and end-to-end client engagement services. Competitors range from large, diversified players to specialized niche providers, all vying for market share through innovation, cost efficiency, and service quality.

Regulatory Implications

The company faces potential impacts from new accounting pronouncements, which could alter financial reporting standards and require adjustments. Compliance with global data privacy regulations (e.g., GDPR, CCPA) is also critical, as breaches or non-compliance can lead to significant fines and reputational damage.

What Investors Should Do

  1. Monitor Webhelp integration progress
  2. Analyze margin trends
  3. Evaluate share repurchase activity

Key Dates

Glossary

Goodwill
An intangible asset that arises when a company acquires another company for a price greater than the fair value of its identifiable net assets. (Represents a significant portion of Concentrix's assets ($5.19B as of Aug 31, 2025), primarily from acquisitions like Webhelp, indicating growth through M&A.)
Accumulated other comprehensive loss
A component of equity that includes unrealized gains and losses on certain investments, foreign currency translation adjustments, and pension adjustments. (A decrease from ($414.3M) to ($209.1M) indicates a positive movement, potentially due to favorable foreign currency translations or other factors, improving total equity.)
Treasury stock
Stock that a company has repurchased from the open market. (An increase in treasury stock (from $421.5M to $538.0M) reflects the company's share repurchase activity, reducing the number of outstanding shares and potentially boosting EPS.)
Diluted EPS
Earnings per share calculated by dividing net income by the total number of diluted shares outstanding, including all convertible securities and stock options. (The significant increase in diluted EPS (from $0.25 to $1.34 for Q3) highlights improved profitability on a per-share basis, driven by higher net income and potentially fewer outstanding shares.)

Year-Over-Year Comparison

Compared to the prior year period, Concentrix has demonstrated robust top-line growth, with revenue increasing by 4.0% to $2.48 billion for the three months ended August 31, 2025. Net income saw a dramatic surge of 430% to $88.11 million, indicating significant improvements in profitability. While total assets and liabilities have grown, the company's cash position has strengthened considerably, rising to $350.26 million from $240.57 million. New risks related to accounting pronouncements are being evaluated, and the integration of the Webhelp acquisition continues to be a key factor influencing financial performance.

Filing Stats: 4,711 words · 19 min read · ~16 pages · Grade level 20 · Accepted 2025-10-03 08:04:36

Key Financial Figures

Filing Documents

FINANCIAL INFORMATION

PART I FINANCIAL INFORMATION 2

Financial Statements

Item 1. Financial Statements 2 Consolidated Balance Sheets as of August 31, 2025 (unaudited) and November 30, 2024 2 Consolidated Statements of Operations (unaudited) for the Three and Nine Months Ended August 31, 2025 and 2024 3 Consolidated Statements of Comprehensive Income (unaudited) for the Three and Nine Months Ended August 31, 2025 and 2024 4 Consolidated Statements of Stockholders' Equity (unaudited) for the Three and Nine Months Ended August 31, 2025 and 2024 5 Consolidated Statements of Cash Flows (unaudited) for the Nine Months Ended August 31, 2025 and 2024 7 Notes to the Consolidated Financial Statements (unaudited) 8

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 28

Quantitative and Qualitative Disclosures About Market Risk

Item 3. Quantitative and Qualitative Disclosures About Market Risk 43

Controls and Procedures

Item 4. Controls and Procedures 44

OTHER INFORMATION

PART II OTHER INFORMATION 45

Legal Proceedings

Item 1. Legal Proceedings 45

Risk Factors

Item 1A. Risk Factors 45 Item 2. Unregistered S ales of E quity S ecurities and U se of P roceeds 45 Item 5. Other Information 45

Exhibits

Item 6. Exhibits 46

—FINANCIAL INFORMATION

PART I—FINANCIAL INFORMATION

FINANCIAL STATEMENTS

ITEM 1. FINANCIAL STATEMENTS CONCENTRIX CORPORATION CONSOLIDATED BALANCE SHEETS (currency and share amounts in thousands, except par value) August 31, 2025 November 30, 2024 (unaudited) ASSETS Current assets: Cash and cash equivalents $ 350,259 $ 240,571 Accounts receivable, net 2,051,920 1,926,737 Other current assets 735,332 675,116 Total current assets 3,137,511 2,842,424 Property and equipment, net 733,306 714,517 Goodwill 5,191,565 4,986,967 Intangible assets, net 2,079,278 2,286,940 Deferred tax assets 282,486 218,396 Other assets 985,953 942,194 Total assets $ 12,410,099 $ 11,991,438 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable $ 221,570 $ 209,812 Current portion of long-term debt 37,500 2,522 Accrued compensation and benefits 698,890 706,619 Other accrued liabilities 969,868 977,314 Income taxes payable 81,355 99,546 Total current liabilities 2,009,183 1,995,813 Long-term debt, net 4,790,293 4,733,056 Other long-term liabilities 964,086 910,271 Deferred tax liabilities 302,408 312,574 Total liabilities 8,065,970 7,951,714 Commitments and contingencies (Note 13) Stockholders' equity: Preferred stock, $ 0.0001 par value, 10,000 shares authorized and no shares issued and outstanding as of August 31, 2025 and November 30, 2024, respectively — — Common stock, $ 0.0001 par value, 250,000 shares authorized; 69,120 and 68,849 shares issued as of August 31, 2025 and November 30, 2024, respectively, and 62,209 and 64,238 shares outstanding as of August 31, 2025 and November 30, 2024, respectively 7 7 Additional paid-in capital 3,765,512 3,683,608 Treasury stock, 6,911 and 4,611 shares as of August 31, 2025 and November 30, 2024, respectively ( 537,966 ) ( 421,449 ) Retained earnings 1,325,693 1,191,871 Accumulated other comprehensive loss ( 209,117 ) ( 414,313 ) Total stockholders' equity 4,344,129 4,039,724 Total liabilities and stockholders' equity $ 12,410,099 $ 11,991,438 The accompanyin

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing